Ozempic Vision Loss Lawsuit — August 2026 Status: More than 200 lawsuits alleging that Ozempic and other GLP-1 drugs caused sudden, permanent vision loss (NAION) are now consolidated in federal court (MDL 3163, Eastern District of Pennsylvania, Judge Karen S. Marston). The case count more than doubled between May and August 2026. Alabama patients generally have two years from injury to file. Consultations are free: (205) 407-6009.

Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 medications have transformed diabetes care and weight loss, but for a small group of patients, these drugs are now linked to a devastating side effect: non-arteritic anterior ischemic optic neuropathy (NAION), a sudden loss of vision that is usually painless, often discovered on waking, and typically permanent. If you took a GLP-1 medication and suffered sudden vision loss in one or both eyes, Fob James Law Firm is reviewing Alabama cases now.

What Is NAION and How Is It Linked to Ozempic?

NAION is often described as a “stroke of the optic nerve.” Blood flow to the front of the optic nerve is interrupted, nerve tissue dies, and the vision it served does not come back. There is no established treatment that reverses NAION once it happens.

In 2024, researchers at Harvard’s Massachusetts Eye and Ear reported that patients taking semaglutide (the active drug in Ozempic and Wegovy) developed NAION at several times the expected rate — a reported 4.3x higher risk in diabetic patients and roughly 7.6x higher in patients taking it for weight loss. In June 2025, the European Medicines Agency concluded NAION is a “very rare” side effect of semaglutide and required label changes in Europe. As of August 2026, the FDA has not required a NAION warning on U.S. labels — a central allegation in the litigation.

The GLP-1 Vision Loss Litigation (MDL 3163)

In December 2025, the Judicial Panel on Multidistrict Litigation consolidated GLP-1/NAION lawsuits into MDL 3163 before Judge Karen S. Marston in the Eastern District of Pennsylvania. The defendants are Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro, Zepbound). Plaintiffs allege the manufacturers knew or should have known of the NAION signal and failed to warn patients and doctors.

Where things stand (August 2026): roughly 200 cases were pending in the MDL as of early August, up from 86 in May, and the court held a “Science Day” in June 2026 where both sides presented the medical evidence on the semaglutide–NAION link. The litigation is early: no bellwether trials have been scheduled and no settlements have been announced.

Who May Qualify for an Ozempic Vision Loss Claim in Alabama

  • You were prescribed Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, or Victoza (prescription use, not compounded or gray-market versions); and
  • You were diagnosed with NAION or suffered sudden, painless vision loss, often described as blurry or dim vision on waking, a dark or shadowed area in one eye’s field, or sudden partial or full vision loss; and
  • The vision loss came after you started the medication.

Bring whatever records you have: prescription history, ophthalmology records, and the date your vision changed. We will handle the rest of the workup.

The Alabama Filing Deadline

Alabama’s statute of limitations for personal injury claims is generally two years (Ala. Code § 6-2-38). For a vision-loss claim, the clock usually starts at the injury. Waiting costs evidence even when it doesn’t cost the claim. If your vision loss was recent, the best time to call is now.

Why Call Fob James Law Firm

We are a Birmingham-based injury firm that handles mass tort claims for Alabama families, and our attorneys work alongside the national litigation teams prosecuting the GLP-1 cases. You get local counsel who answers the phone and a seat at the national table. There is no fee unless we recover for you.

Ozempic Vision Loss Lawsuit FAQs

Is there a class action for Ozempic vision loss?

Not a class action. The cases are consolidated in a multidistrict litigation (MDL 3163) in Pennsylvania federal court. Each plaintiff keeps an individual claim valued on their own injuries, which for permanent vision loss can be substantial.

How much does it cost to file an Ozempic lawsuit?

Nothing up front. We handle GLP-1 vision loss cases on a contingency fee. The consultation is free and we only get paid if we recover money for you.

What if I took Wegovy, Mounjaro, or Zepbound instead of Ozempic?

The litigation covers the GLP-1 class, including Novo Nordisk’s Ozempic, Wegovy, and Rybelsus and Eli Lilly’s Mounjaro and Zepbound. If you took any GLP-1 medication and suffered sudden vision loss, you may qualify.

How long do I have to file in Alabama?

Generally two years from the injury under Alabama’s statute of limitations, and the practical window for building a strong case is shorter. A free attorney case review will pin down your specific deadline.

Talk to an Alabama Ozempic Lawyer Today

Sudden vision loss changes everything — work, driving, independence. If it happened after a GLP-1 prescription, you deserve answers and, if the evidence supports it, compensation. Call Fob James Law Firm, LLC at (205) 407-6009 or contact us online. 2226 1st Ave S, Suite 105, Birmingham, AL 35233. Free consultation, no fee unless we win.